HSBC Holdings
ANIP icon

HSBC Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

HSBC Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
+5,952
New +$477K ﹤0.01% 2285
2019
Q4 		– Sell
-7,094
Closed -$517K – 3022
2019
Q3 		$517K Buy
+7,094
New +$531K ﹤0.01% 2319

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's ANIP Position: Q2 2026 in Review

HSBC Holdings opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 5,952 shares worth $499K. The stake represents ﹤0.01% of the portfolio and ranks #2285 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in ANIP as recently as Q3 2019.

HSBC Holdings first reported a position in ANIP in Q3 2019 and has held it in 2 quarters since. The position peaked at $517K in Q3 2019. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • HSBC Holdings held 5,952 shares of ANI Pharmaceuticals worth $499K as of Q2 2026.
  • ANI Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2285 holding.
  • HSBC Holdings first reported a position in ANI Pharmaceuticals in Q3 2019 and has held it in 2 quarters since.
  • HSBC Holdings's ANI Pharmaceuticals position peaked at $517K in Q3 2019.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.